Cytokinetics, Incorporated (CYTK) vs Protagonist Therapeutics, Inc. (PTGX)

Cytokinetics, Incorporated and Protagonist Therapeutics, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and Protagonist Therapeutics, Inc. are of similar size ($9.0B and $8.9B). Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 117×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against −21.1%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −1,321.1%) and the higher return on invested capital (61.8% vs 0.00%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 13 and Cytokinetics, Incorporated on 4.